BioWorld

Dec. 28, 1999

View Archived Issues

Other News To Note

Read More

Genta Completes Financing To Advance Antisense Drugs

Read More

Neurocrine Raises $42M In Private Placement Of Stock

Read More

Cambridge Antibody, Searle In Pact Valued Up To $212M

Read More

Interneuron, Warner-Lambert In Potential $74M Anti-Anxiety Deal

Read More

Neurofibromatosis Models Could Help Understanding Of Tumor Development

Read More